Macrogenics (MGNX) Short-term Investments (2015 - 2019)

Macrogenics (MGNX) has reported Short-term Investments for 5 consecutive years, with $89.3 million the latest figure, recorded in Q4 2019.

• In Q4 2019, Short-term Investments rose 601.09% year-over-year to $89.3 million; the TTM figure through Dec 2019 stood at $89.3 million (up 601.09% YoY), while the FY2019 annual figure was $89.3 million, up 601.09% from the prior year.
• Short-term Investments climbed to $89.3 million in Q4 2019 per MGNX's latest filing, from $12.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $192.9 million in Q4 2016 and bottomed at $12.7 million in Q4 2018.
• Historically, Short-term Investments has averaged $106.2 million across 5 years, with a median of $93.4 million in 2017.
• Annual changes were most pronounced in 2018 — Short-term Investments plunged 86.36% — and 2019, when it soared 601.09%.
• Macrogenics' Short-term Investments stood at $142.9 million in 2015, then jumped by 35.01% to $192.9 million in 2016, then plunged by 51.58% to $93.4 million in 2017, then slumped by 86.36% to $12.7 million in 2018, then jumped by 601.09% to $89.3 million in 2019.
• Business Quant data shows MGNX's Short-term Investments at $89.3 million in Q4 2019, $12.7 million in Q4 2018, and $93.4 million in Q4 2017.